Secondary Logo

Journal Logo


Endoscopic Surveillance of Duodenal Polyposis After Total Gastrectomy in Familial Adenomatous Polyposis

Shah, Ravi S. MD1; Mehta, Neal MD2; Mankaney, Gautam MD2; Walsh, Matthew R. MD3; Burke, Carol A. MD2; Bhatt, Amit MD2

Author Information
doi: 10.14309/crj.0000000000000445
  • Open



Duodenal cancer is the second most common malignancy in familial adenomatous polyposis (FAP). Upper endoscopic surveillance with visualization of the ampulla, and removal of duodenal polyps >10 mm, is recommended starting at the age of age 20–25 years.1 The Spigelman stage of duodenal polyposis guides the frequency of endoscopic surveillance and need for duodenectomy. Although more uncommon than duodenal cancer, the incidence of gastric adenocarcinoma is increasing in FAP. Gastric cancer occurs in the proximal stomach usually in the setting of massive, proximal gastric polyposis.2 A thoughtful surgical approach is prudent for patients with FAP found to have curative gastric adenocarcinoma or gastric polyposis with high-grade dysplasia. Total gastrectomy is the preferred approach for the management of advanced gastric neoplasia, provided that mesenteric desmoids do not negatively affect restoring gastrointestinal continuity. A standard 50–60 cm Roux limb, with or without an aboral jejunal pouch, is performed after gastrectomy, making subsequent endoscopic surveillance of the duodenum difficult. There is a lack of data on duodenal surveillance in patients who have undergone gastrectomy. We report the utility of anterograde balloon enteroscopy in a patient with FAP after total gastrectomy. The identification and resection of large duodenal polyps with this approach highlights the technical feasibility and importance of continued duodenal surveillance after gastrectomy in FAP.


A 66-year-old woman with FAP and a history of colectomy with ileorectal anastomosis underwent upper endoscopic surveillance revealing Spigelman stage III duodenal polyposis (>20 polyps, >10 mm in size, and histology of low-grade tubular adenoma) and advanced gastric polyposis with biopsies consistent with intramucosal adenocarcinoma.3 Risks and benefits of the difficulty of continued duodenal surveillance after gastrectomy were discussed with the patient, and simultaneous duodenectomy was not offered at this time. Total gastrectomy with Roux-en-Y esophagojejunostomy and an aboral isoperistaltic pouch was performed, and a T1a gastric adenocarcinoma was diagnosed on final pathology. One year after gastrectomy, a standard esophagogastroduodenoscopy was unsuccessful at reaching the duodenum. Thereafter, a single balloon enteroscope was successfully passed to the jejunojejunal anastomosis into the Y limb to the end of the duodenum (Figure 1). A 30-mm sessile polyp and a 20-mm laterally spreading tumor-granular type polyp were removed with endoscopic mucosal resection (Figure 2).

Figure 1.
Figure 1.:
Esophagojejunostomy with aboral pouch anatomy.
Figure 2.
Figure 2.:
Large duodenal polyps accessed through Roux-en-Y esophagojejunostomy with aboral pouch in a familial adenomatous polyposis patient.


This case highlights the importance and challenges of duodenal surveillance in patients with FAP who require total gastrectomy. Although it was possible to reach the duodenum with balloon enterosocopy in our patient, this might not be possible in similar cases after gastrectomy and Roux-en-Y esophagojejunostomy reconstruction because adhesions with fixed segments of bowel, or desmoids, can limit deep insertion of balloon enteroscopes. In addition, endoscopic interventions can be difficult through a deeply inserted balloon enteroscope because both the passage of devices through the accessory channel and scope maneuverability can be limited, making complex endoscopic mucosal resection and management of its possible complications challenging to perform. In addition, if an ampullary adenoma is present, attempting an endoscopic papillectomy would be exceedingly challenging to perform through a balloon enteroscope. Surgically, performing a gastrectomy with jejunal interposition, rather than gastrectomy with Roux-en-Y esophagojejunostomy, would facilitate duodenal endoscopic access; however, this surgical approach is associated with disabling symptomatic bile reflux after the loss of the pylorus and lower esophageal sphincter.4–6 The duodenal polyposis burden must be considered when determining simultaneous management of the duodenum and stomach. A tailored surgical approach including complete duodenectomy may be considered for definitive management of severe polyposis after gastrectomy but is fortunately rarely required.7 Future studies are needed to evaluate the long-term risk of duodenal and ampullary malignancy in patients with FAP undergoing gastrectomy with Roux-en-Y esophagojejunostomy and to explore other surgical reconstruction techniques, enhancing the feasibility and technical success of duodenal surveillance. We recommend endoscopic removal of large or histologically advanced duodenal or ampullary lesions before gastrectomy, and if Spigelman stage IV polyposis is present, duodenectomy should be performed. After surgery, balloon enteroscopy should be standardly used for duodenal polyposis surveillance and removal of large polyps in the duodenum.


Author contributions: RS Shah wrote the manuscript. N. Mehta, G. Mankaney, MR Walsh, CA Burke, and A. Bhatt revised the manuscript for intellectual content. A. Bhatt is the article guarantor.

Financial disclosure: None to report.

Informed consent was obtained for this case report.


1. Yang J, Gurudu SR, Koptiuch C, et al. American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in familial adenomatous polyposis syndromes. Gastrointest Endosc. 2020;90:963–82.e2.
2. Mankaney G, Leone P, Cruise M, et al. Gastric cancer in FAP: A concerning rise in incidence. Fam Cancer. 2017;16(3):371–6.
3. Leone PJ, Mankaney G, Sarvapelli S, et al. Endoscopic and histologic features associated with gastric cancer in familial adenomatous polyposis. Gastrointest Endosc. 2019;89:961–8.
4. Fan KX, Xu ZF, Wang MR, Li DT, Yang XS, Guo J. Outcomes for jejunal interposition reconstruction compared with Roux-en-Y anastomosis: A meta-analysis. World J Gastroenterol. 2015;21(10):3093–9.
5. Spigelman A, Williams CB, Talbot IC, Domizio P, Phillips RK. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet. 1989;334(8666):783–5.
6. Mahmoud NN, Dannenberg AJ, Bilinski RT, et al. Administration of an unconjugated bile acid increases duodenal tumors in a murine model of familial adenomatous polyposis. Carcinogenesis. 1999;20:299–303.
7. Kawamoto Y, Ome Y, Kouda Y, et al. Pancreaticoduodenectomy following gastrectomy reconstructed with Billroth II or Roux-en-Y method: Case series and literature review. Int J Surg Case Rep. 2017;35:106–9.
© 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.